Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion type Assertion NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_head.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion description "[These data provide compelling evidence that 17-AAG may be effective in the treatment of c-kit-related diseases including mastocytosis, GISTs, mast cell leukemia, subtypes of acute myelogenous leukemia, and testicular cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_provenance.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion evidence source_evidence_literature NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_provenance.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion SIO_000772 14551138 NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_provenance.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion wasDerivedFrom befree-2016 NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_provenance.
- NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_assertion wasGeneratedBy ECO_0000203 NP416352.RAXOKkr0-UPQcNwJBk1py2exUfMfkyjb2NKICGTKHNtmA130_provenance.